Cargando…
Receptor-Mediated Melanoma Targeting with Radiolabeled α-Melanocyte-Stimulating Hormone: Relevance of the Net Charge of the Ligand
A majority of melanotic and amelanotic melanomas overexpress melanocortin type 1 receptors (MC1Rs) for α-melanocyte-stimulating hormone. Radiolabeled linear or cyclic analogs of α-MSH have a great potential as diagnostic or therapeutic tools for the management of malignant melanoma. Compounds such a...
Autores principales: | Bapst, Jean-Philippe, Eberle, Alex N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405074/ https://www.ncbi.nlm.nih.gov/pubmed/28491052 http://dx.doi.org/10.3389/fendo.2017.00093 |
Ejemplares similares
-
Alpha-melanocyte stimulating hormone (α-MSH): biology, clinical relevance and implication in melanoma
por: Dall’Olmo, Luigi, et al.
Publicado: (2023) -
Desacetyl-α-melanocyte stimulating hormone and α-melanocyte stimulating hormone are required to regulate energy balance
por: Mountjoy, Kathleen G., et al.
Publicado: (2017) -
Melanoma cell migration is upregulated by tumour necrosis factor-α and suppressed by α-melanocyte-stimulating hormone
por: Zhu, N, et al.
Publicado: (2004) -
Ligands for Melanocortin Receptors: Beyond Melanocyte-Stimulating Hormones and Adrenocorticotropin
por: Yuan, Xiao-Chen, et al.
Publicado: (2022) -
Anti-inflammatory and anti-invasive effects of α-melanocyte-stimulating hormone in human melanoma cells
por: Eves, P, et al.
Publicado: (2003)